Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Strang

Showing results (251-260 of 303) with videos related to

Pageof 31
Sort By:
Harm Reduction Journal|March 22, 2017
The acceptability and feasibility of a brief psychosocial intervention to reduce blood-borne virus risk behaviours among people who inject drugs: a randomised control feasibility trial of a psychosocial intervention (the PROTECT study) versus treatment as usualGail Gilchrist, Davina Swan, April Shaw, et al.
The Lancet. Infectious Diseases|September 26, 2016
Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013Louisa Degenhardt, Fiona Charlson, Jeff Stanaway, et al.
European Addiction Research|February 3, 2022
Take-Home Naloxone Kits: Attitudes and Likelihood-Of-Use Outcomes from a European Survey of Potential Overdose WitnessesRebecca McDonald, Sibella Breidahl, Katri Abel-Ollo, et al.
Journal of Substance Abuse Treatment|August 20, 2020
Factors associated with withdrawal symptoms and anger among people resuscitated from an opioid overdose by take-home naloxone: Exploratory mixed methods analysisJoanne Neale, Nicola J Kalk, Stephen Parkin, et al.
Medical Image Computing and Computer-Assisted Intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention|March 16, 2007
Robot-assisted prostate brachytherapyYan Yu, Tarun Podder, Yongde Zhang, et al.
Addiction (Abingdon, England)|December 22, 2023
Human costs of healthcare resilience during the war in Ukraine: Lessons from addiction and HIV treatmentJulia Rozanova, Irina Zaviryukha, Alexandra A Deac, et al.
Lancet (London, England)|June 1, 2010
Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomised trialJohn Strang, Nicola Metrebian, Nicholas Lintzeris, et al.
Addiction (Abingdon, England)|February 11, 2025
A heroin overdose laboratory model: How do escalating doses of diamorphine alter respiratory function in a diamorphine-treated population?Basak Tas, Nicola J Kalk, Edward Chesney, et al.
Health Technology Assessment (Winchester, England)|December 7, 2017
Preventing blood-borne virus infection in people who inject drugs in the UK: systematic review, stakeholder interviews, psychosocial intervention development and feasibility randomised controlled trialGail Gilchrist, Davina Swan, April Shaw, et al.
Addiction (Abingdon, England)|March 19, 2016
An economic evaluation of contingency management for completion of hepatitis B vaccination in those on treatment for opiate dependenceRachid Rafia, Peter J Dodd, Alan Brennan, et al.
Pageof 31

Showing results (251-260 of 303) with videos related to

Sort By:
Pageof 31
Harm Reduction Journal|March 22, 2017
The acceptability and feasibility of a brief psychosocial intervention to reduce blood-borne virus risk behaviours among people who inject drugs: a randomised control feasibility trial of a psychosocial intervention (the PROTECT study) versus treatment as usualGail Gilchrist, Davina Swan, April Shaw, et al.
The Lancet. Infectious Diseases|September 26, 2016
Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013Louisa Degenhardt, Fiona Charlson, Jeff Stanaway, et al.
European Addiction Research|February 3, 2022
Take-Home Naloxone Kits: Attitudes and Likelihood-Of-Use Outcomes from a European Survey of Potential Overdose WitnessesRebecca McDonald, Sibella Breidahl, Katri Abel-Ollo, et al.
Journal of Substance Abuse Treatment|August 20, 2020
Factors associated with withdrawal symptoms and anger among people resuscitated from an opioid overdose by take-home naloxone: Exploratory mixed methods analysisJoanne Neale, Nicola J Kalk, Stephen Parkin, et al.
Medical Image Computing and Computer-Assisted Intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention|March 16, 2007
Robot-assisted prostate brachytherapyYan Yu, Tarun Podder, Yongde Zhang, et al.
Addiction (Abingdon, England)|December 22, 2023
Human costs of healthcare resilience during the war in Ukraine: Lessons from addiction and HIV treatmentJulia Rozanova, Irina Zaviryukha, Alexandra A Deac, et al.
Lancet (London, England)|June 1, 2010
Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomised trialJohn Strang, Nicola Metrebian, Nicholas Lintzeris, et al.
Addiction (Abingdon, England)|February 11, 2025
A heroin overdose laboratory model: How do escalating doses of diamorphine alter respiratory function in a diamorphine-treated population?Basak Tas, Nicola J Kalk, Edward Chesney, et al.
Health Technology Assessment (Winchester, England)|December 7, 2017
Preventing blood-borne virus infection in people who inject drugs in the UK: systematic review, stakeholder interviews, psychosocial intervention development and feasibility randomised controlled trialGail Gilchrist, Davina Swan, April Shaw, et al.
Addiction (Abingdon, England)|March 19, 2016
An economic evaluation of contingency management for completion of hepatitis B vaccination in those on treatment for opiate dependenceRachid Rafia, Peter J Dodd, Alan Brennan, et al.
Pageof 31